Tracked deals
3346
3346 tracked deals across 2008-2026.
Tracked deals
3346
3346 tracked deals across 2008-2026.
Buyer mix
Mixed buyer set
3265 pe · 1953 strategic
Top trend
Volume peaked in 2021
578 tracked deals announced in 2021.
Buyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| NMS Capital | 64 | Private equity firm focused on lower middle market invest... | PE |
| The Riverside Company | 29 | Global private equity firm focused on the smaller end of ... | PE |
| Gryphon Investors | 28 | Middle-market private equity firm and sponsor; provides c... | PE |
| Revelstoke Capital Partners | 26 | Healthcare-focused private equity firm that partners with... | PE |
| Sheridan Capital Partners | 25 | Chicago-based healthcare private equity firm focused on l... | PE |
| H.I.G. Capital | 22 | Global alternative investment firm providing equity and d... | PE |
| HCAP Partners | 22 | Southern California-based private equity and mezzanine de... | PE |
| Linden Capital Partners | 22 | Healthcare-focused private equity firm investing in middl... | PE |
| InTandem Capital Partners | 21 | Private equity firm focused on investing in and growing h... | PE |
| Ampersand Capital Partners | 20 | Middle-market private equity firm focused on growth-orien... | PE |
Last 10 years
Supporting Data
Kincell Bio and Cellipont Bioservices completed their merger to create Kincellis Advanced Therapies, a scaled U.S. contract development and manufacturing organization (CDMO) focused on cell therapies and other advanced modalities. The combined platform spans early development through commercial supply across multiple sites in Florida, North Carolina, and Texas, with the equity financing led by NewSpring Capital and debt support from J.P. Morgan.
Allyant acquired Braille Works, expanding its alternative-format production capabilities across braille, large print, audio, and accessible PDFs. The transaction also increases Allyant’s capacity and adds a Florida production presence, while preserving Braille Works’ accessibility-focused operating model. Financial terms were not disclosed.
Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.
L Catterton and Altas Partners agreed to acquire a majority stake in Fullscript from HGGC and Snapdragon Capital Partners. The investment is intended to support Fullscript’s next phase of expansion, including growth of its platform and clinical support capabilities, ahead of a planned close in Q4 2026 subject to regulatory approvals and customary conditions.
Spire Healthcare Group has agreed to be acquired by a consortium of funds managed by Toscafund Asset Management, Three Hills and Ares in a deal valuing the UK private healthcare operator at about £1.026 billion. The consortium will pay 250 pence per Spire share, representing a 66% premium to the company’s market capitalization on May 13, and shareholders holding about 53.4% have agreed to support the offer.
LUX Infusion acquired two ambulatory infusion centers—South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey and Northeast Infusion Therapy in Latham, New York. The acquisitions expand LUX Infusion’s ambulatory infusion center footprint and support its clinician-led model of patient-centered, physician-collaborative infusion care.
Hanger has agreed to acquire Numotion for cash, combining orthotic and prosthetic patient care with Complex Rehabilitation Technology (CRT) and mobility and independence solutions. The combined organization will continue operating under existing brands and is expected to close in the fourth quarter of 2026, subject to customary conditions.
Danforth Health, Inc., a portfolio company of Avesi Partners, acquired Ambit RD, Inc. Ambit is a technology-enabled solutions provider focused on serving rare and specialty biopharma markets with commercial strategy, advanced analytics, and patient identification solutions.
Olympus Cosmetic Group acquired Gallaher Plastic Surgery & Med Spa, a cosmetic plastic surgery and med spa practice in Eastern Tennessee. The deal expands Olympus’ surgeon-founded aesthetics platform into Tennessee, with the practice continuing under its physician-led approach led by Dr. Tom Gallaher.
Marwood Group, a healthcare-focused advisory and consulting firm, received a strategic investment from funds managed by Lee Equity Partners. The firm also named Chris Librizzi as Chief Executive Officer, alongside Richard Jeanneret joining as Executive Chairman.
H.I.G. Capital, through an affiliate, completed the acquisition of Outcomes One (Outcomes), an Orlando-based provider of clinical network services and pharmacy technology. Outcomes operates a national clinical network covering about 85% of U.S. pharmacies and offers an integrated technology suite including pharmacy management software and workflow automation platforms such as Rx30, Computer-Rx, and Outcomes Premium.
Liberty Restoration Group has completed its acquisition of ServiceMaster Restoration Services by KRS, adding three new offices in Peoria and Bloomington, Illinois, and Milwaukee, Wisconsin. The deal expands Liberty’s multi-market disaster restoration and reconstruction platform to eight Midwest markets following its April acquisition of ServiceMaster of Columbia in Missouri.
BPOC, a healthcare-focused investment firm, made strategic investments in Master Medical Equipment (MME) and ReNew Biomedical, sister companies that distribute, rent, repair, and maintain medical equipment. The companies plan to use BPOC’s backing to expand their geographic footprint and broaden their range of healthcare equipment and service solutions, with founder and CEO Mark Taylor continuing to lead both businesses.
SuperiorMed Holdings entered into a definitive merger agreement with Starry Sea Acquisition Corp., expected to take the Dubai-based healthcare management and services platform public via a SPAC transaction. Under the structure, Starry Sea will merge with and into SuperiorMed Healthcare Group, and a separate merger subsidiary will combine with SuperiorMed, leaving SuperiorMed as a wholly owned subsidiary of the publicly listed parent.
Linden Capital Partners has acquired ArtesRx, a behavioral health pharmacy platform, from Flexpoint Ford. ArtesRx was founded in 2023 and expanded its footprint from three pharmacies in one state to 16 pharmacies serving patients across 15 states.
Seacoast Capital announced a non-control growth capital investment in Aarista to support a balance sheet recapitalization. The firm provided subordinated debt to help recapitalize certain existing indebtedness and provide working capital for Aarista’s continued growth.
Francisco Partners has entered into a definitive agreement to acquire Weave Communications for approximately $650 million in an all-cash transaction at $7.40 per share, representing about a 34% premium. The deal is expected to close in the fourth quarter of 2026, after stockholder and regulatory approvals, and Weave will become private and cease trading on the NYSE.
Carepoint Pharmacy, an end-to-end access hub and dispensing pharmacy, announced a partnership and investment from New Heritage Capital. The investment uses Heritage’s “Private IPO” structure, which is designed to leave operating control with Carepoint’s current management while providing financial flexibility for growth. Terms were not disclosed.
JLL Partners completed its acquisition of Life Couriers, a Munich-headquartered provider of time-critical healthcare logistics for radiopharmaceutical and life sciences shipments. The deal also includes the appointment of Edward DeMartini as CEO as Life Couriers plans to expand its geographic footprint with additional investment in people and operations.
DocGo has entered into a definitive agreement to acquire Hicuity Health, a virtual care provider offering high acuity virtual clinical services including Tele-ICU and virtual nursing. DocGo will acquire Hicuity in exchange for assuming Hicuity’s existing indebtedness (held by Perceptive Advisors) and Perceptive Advisors will also commit additional debt financing to DocGo.
Affordable Care, LLC, a national dental support organization (DSO), completed a sweeping debt restructuring that removes more than $1 billion of debt and injects $75 million in fresh capital. Under the terms, the former private equity sponsors are wiped out and the reorganized company is owned by its direct lenders, including Blackstone and KKR & Co.
The Riverside Company has invested in Yellow Emperor, a contract development and manufacturing organization (CDMO) specializing in custom liquid dietary supplement formulations. The deal represents the first add-on investment for Riverside’s portfolio company, Western Botanicals, expanding its liquid manufacturing capabilities and positioning it as a broader formulator and manufacturing partner for health and wellness brands.
Surplus Solutions LLC, an NMS Capital portfolio company, acquired Boston Industries, a Walpole, Massachusetts-based specialist in technical repair and refurbishment of laboratory instruments. The deal expands Surplus Solutions’ in-house lab repair capabilities across flow cytometry, microscopy, liquid handling, and other core instrument categories. Terms were not disclosed.
Currier Plastics (portfolio company of Currier Plastics) has completed the strategic acquisition of Sage Product Development, an engineering, design, and development provider focused on medical devices. Sage’s services span early concept and feasibility, product development and project management, and contract manufacturing for a wide range of device types.
Tortuga Growth Partners (TGP) made a strategic investment in Advanced eClinical Training (ACT), an online provider of healthcare certifications and workforce development. The deal is intended to accelerate ACT’s national scaling of technology-enabled training and certification programs that prepare frontline clinical professionals, addressing a growing U.S. healthcare labor shortage.
KKR has signed definitive agreements to acquire Medicover India, the Indian hospital operations of Medicover AB, which operates 24 hospitals with approximately 4,800 beds across South and West India. KKR plans to support the hospital operator’s next phase of growth by investing in talent, technology, infrastructure, and clinical capabilities, while reinforcing clinical governance and operating standards.
ClaimsBridge announced a strategic investment from Eir Partners Capital to scale its end-to-end claim and network technology ecosystem for healthcare payers. In parallel, ClaimsBridge acquired DialysisPPO, which offers a patented ESRD and chronic dialysis cost containment program aimed at helping payers capture Medicare savings immediately.
Charterhouse Capital Partners has completed its acquisition of Animalcare Group after the animal healthcare company was delisted from the London Stock Exchange’s AIM market. Financial terms were not disclosed. The deal positions Animalcare as a platform for continued innovation, international expansion, and additional strategic acquisitions in the global animal health sector.
ACT LAB, a multistate cannabis and hemp testing and compliance laboratory network, announced an expansion into New Jersey. The expansion follows its acquisition of Sriven Labs (SV Labs – NJ), a licensed cannabis testing laboratory serving New Jersey’s regulated cannabis market, and aims to improve local testing capacity and turnaround times while maintaining standardized methodologies.
Sheridan Capital Partners has completed its investment in Carolina Components Group (CCG), a Durham, North Carolina-based provider of custom-engineered bioprocessing assemblies and ultra-pure components used in biopharmaceutical manufacturing. Concurrent with the investment, CCG named Maurice Phelan as its new CEO, while founder John Cooling joined the board and retains an equity interest.
Isto Biologics announced the acquisition of NovaBone Products LLC, a developer and manufacturer of synthetic bone graft products, from Halma plc. The deal, supported by Keensight Capital, adds NovaBone’s bioactive glass technologies to Isto’s bone graft substitutes platform and expands its geographic reach and surgical end-market presence.
Craftech Holdco, a portfolio company of Sage Park, acquired Balda C. Brewer (BCB), an Ontario, California-based contract manufacturing injection molding subsidiary, from Stevanato Group S.p.A. The deal expands the combined platform’s medical cleanroom injection molding capabilities and manufacturing footprint across the United States and Mexico.
BWX Technologies, Inc. (BWXT) has entered into a definitive agreement to sell its medical business to Nordic Capital for up to $800 million. The transaction includes BWXT Medical and Kinectrics’ stable medical isotopes business, and BWXT expects the deal to close by the end of 2026 subject to regulatory approvals.
Curium US Holdings LLC has entered into a definitive agreement to acquire all outstanding shares of Lantheus Holdings, Inc. for $102.50 per share in cash at closing, plus non-transferable Contingent Value Rights (CVRs) potentially paying up to an additional $12.00 per share tied to commercial milestones through 2030. The transaction is valued at up to approximately $8.0 billion and is expected to close in the first half of 2027, subject to customary approvals and regulatory clearances.
KKR has entered into a definitive agreement to acquire Integer Holdings Corporation in an all-cash transaction valued at approximately $5.7 billion. Under the terms of the deal, Integer shareholders will receive $127 per share, and the transaction is expected to close by the end of 2026 subject to customary approvals and closing conditions.
PetIQ acquired MYOS Corp and its Fortetropin-based muscle health product portfolio, adding consumer supplements and veterinarian-exclusive formulations to its pet health and wellness platform. The deal gives PetIQ ownership of the MYOS brand and patented Fortetropin ingredient technology, which it plans to scale using its national retail and e-commerce capabilities.
Gerresheimer has entered into definitive agreements to sell Centor and its global Primary Packaging Plastics business to an affiliate of funds advised by Apax Partners, for an enterprise value of about €1.5 billion. The carve-out transactions will be completed through separate deals expected to close independently, subject to customary conditions and regulatory approvals, with Centor targeted for completion by the end of Gerresheimer’s 2026 fiscal year.
Lafayette Instrument, a Branford Castle Partners portfolio company, has acquired Avisoft Bioacoustics to expand its life sciences research instrumentation portfolio. Avisoft supplies ultrasonic microphones, recording systems, and analytical software used in ultrasonic vocalization research for universities and research institutions. Financial terms were not disclosed.
All Star Healthcare Solutions acquired the locums division of Cross Country Healthcare, Inc. The acquired business will initially operate as “Cross Country Locums — an All Star Healthcare Solutions company.” The transaction was completed in conjunction with Knox Lane’s acquisition of Cross Country Healthcare.
The Riverside Company’s Decera Clinical invested in Onviv, Inc. The combination is intended to expand Decera Clinical’s healthcare insights and scientific engagement/medical communications capabilities, including accelerating Onviv’s go-to-market with Decera Clinical’s AI platform, ActivationOS.
Clarion Partners acquired Clearwater at Sonoma Hills, a 94-unit senior living community in Rohnert Park, California, expanding its presence in Northern California’s senior housing market. Clearwater Living will continue as the property’s operating partner following the transaction.
Health Catalyst Capital (HCC), a New York-based private equity firm, acquired a leading Midwest provider of psychiatric care for elderly and disabled adults. MidCap Advisors served as the exclusive financial advisor and the practice plans to expand its regional footprint with HCC’s healthcare network and operational expertise.
KGK Science Inc. received a growth investment led by Maxim Partners to expand its clinical research and regulatory services. The transaction closed on June 30, 2026; financial terms were not disclosed.
Graham Partners completed the July 1, 2026 acquisition of TechData Service Company, LLC (“TechData”) to anchor the newly formed Quantive Intelligence (“QI”) decision sciences platform. QI is being built through Graham’s acquisitions of TechData, LLX Solutions, LLC (“LLX”), and R Square Technology, Inc. (“R Square”), serving pharmaceutical and biotechnology sponsors with biostatistics, statistical programming, and data management services.
KMM Group, a vertically integrated precision contract manufacturer for the medical device industry, announced the completion of an investment by RS2 Healthcare Partners. In connection with the investment, KMM appointed industry veteran J. Mark King as President and Chief Executive Officer, with co-founders John Shegda (Chief Technology Officer) and Eric Wilhelm (Executive VP, Business Transformation & Organizational Capability) taking key leadership roles.
Bain Capital agreed to acquire Vitabiotics, the UK’s leading vitamin company, along with the wider VB Group, including Meyer Organics in India and operations in Africa (including VB Egypt). The deal is intended to support Vitabiotics’ next phase of planned rapid international growth, with the UK expected to remain central to its brand and innovation and no immediate changes to day-to-day operations.
Apex Infusion entered into a definitive agreement to partner with private equity firm SkyKnight Capital to support the company’s next phase of growth. Apex’s clinician-led management team will retain a significant ownership stake and continue to lead, while FFL Partners will remain a minority investor.
The Skin Center, a portfolio company of Footbridge Partners and ALZA Capital Partners, was sold to a leading middle market healthcare private equity fund. Mesirow served as the exclusive financial advisor to The Skin Center, with the transaction described as a recapitalization aimed at accelerating growth across its med spa and cosmetic surgery locations.
Paradigm Oral Health announced a buyback of BlackRock Long Term Private Capital’s ownership stake, returning majority control to its surgeons and management. The buyback is backed by an investment led by Warburg Pincus, in partnership with Goldman Sachs Alternatives and Sixth Street.
Beacon Behavioral Partners entered Michigan and Ohio through an acquisition partnership with Pure Psychiatry, adding a 17-location outpatient behavioral health platform. The deal provides Beacon with its first presence in both states as it expands its regional footprint, while Pure Psychiatry’s clinicians keep ownership stake and clinical autonomy. Financial terms were not disclosed.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.